Optimal dose of dexmedetomidine as an adjuvant to ropivacaine 0.75% with dextrose 80mg used in spinal anesthesia in patients undergoing lower abdominal and lower limb surgeries
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/02/062187
- Lead Sponsor
- Vinayaka Missions Research Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients scheduled for elective lower abdominal and lower limb surgeries under subarachnoid block in VMMCH, Karaikal.
2) Patients of American Society of Anaesthesiologists (ASA) physical status I and II
Exclusion Criteria
1) Patients allergic to any of the drugs used
2) Patients having any absolute contraindications for spinal anesthesia such as patient not willing raised intracranial pressure, severe hypovolemia, bleeding diathesis, local infection and cardiac respiratory, and CNS diseases
3) Patients having hypertension
4) Patients with obesity more than 30kg per meter square
5) Patient with height less than 150cms
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method